Elevated levels of IL1-α at baseline for individuals in the low symptom class as compared to the moderate and severe symptom classes suggest that the IL1-α-mediated pro-inflammatory response may be more robust in patients who are in the low symptom class which could lead to a more efficient response to infection (i.e., more rapid resolution of inflammation due to infection). The gene discussed is IL1A; the disease is infection.